StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report issued on Wednesday. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance Shares of BVXV opened at $1.32 on Wednesday. BiondVax Pharmaceuticals has a 12-month low of $1.25 and a 12-month high of $11.80. The firm […]
BiondVax Pharmaceuticals (NASDAQ:BVXV) Research Coverage Started at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
BiondVax Pharmaceuticals (NASDAQ:BVXV) Now Covered by StockNews com kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report released on Tuesday morning. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Performance Shares of BVXV stock opened at $1.35 on Tuesday. The firm has a market capitalization of $2.52 million, a price-to-earnings ratio of -0.53 […]
StockNews.com initiated coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research note issued to investors on Tuesday. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Trading Up 0.8 % Shares of NASDAQ BVXV opened at $1.31 on Tuesday. The firm has a market cap of $2.45 million, a […]